Mariagrazia Ruvoletto

Via Giustiniani, 2
Padova, 35128, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

1-Piperidine Propionic Acid Inhibits PAR2/SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness.

1-Piperidine Propionic Acid Inhibits PAR2/SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness.

Journal: International journal of molecular sciences

Published: June 10, 2026

Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.

Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.

Journal: British journal of cancer

Published: June 26, 2025

SerpinB3/Protease Activated Receptor-2 Axis Is Essential for SARS CoV-2 Infection.

SerpinB3/Protease Activated Receptor-2 Axis Is Essential for SARS CoV-2 Infection.

Journal: ACS infectious diseases

Published: May 23, 2025

1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition.

1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition.

Journal: International journal of molecular sciences

Published: August 01, 2024

The impact of serpinB3-PD polymorphism on the prognosis of patients with hepatocellular carcinoma.

The impact of serpinB3-PD polymorphism on the prognosis of patients with hepatocellular carcinoma.

Journal: Translational oncology

Published: July 20, 2024

Inhibition of Protease-Activated Receptor-2 Activation in Parkinson's Disease Using 1-Piperidin Propionic Acid.

Inhibition of Protease-Activated Receptor-2 Activation in Parkinson's Disease Using 1-Piperidin Propionic Acid.

Journal: Biomedicines

Published: July 03, 2024

The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis.

The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis.

Journal: Molecular metabolism

Published: October 27, 2023

1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2.

1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 01, 2023

SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness.

SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness.

Journal: Biology

Published: March 07, 2023

Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition.

Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition.

Journal: Biomolecules

Published: February 21, 2023

The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation.

The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation.

Journal: Alimentary pharmacology & therapeutics

Published: February 17, 2023

Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice.

Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice.

Journal: Antioxidants (Basel, Switzerland)

Published: February 17, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026